Matthijs Luxen

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

University of Groningen(Current)

University Medical Center Groningen

Matthijs Luxen is an author at University of Groningen specializing in endothelial activation, sepsis pathophysiology, and anaplastic lymphoma kinase inhibition.

ORCID

Publications per year

2020–2024

Publications

Pharmacological inhibition of focal adhesion kinase 1 (FAK1) and anaplastic lymphoma kinase (ALK) identified via kinome profile analysis attenuates lipopolysaccharide-induced endothelial inflammatory activation

Erna-Zulaikha Dayang, Matthijs Luxen, Timara Kuiper et al. · Biomedicine & Pharmacotherapy · 2020 · 20 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Pharmacological inhibition of protein tyrosine kinases axl and fyn reduces TNF-α-induced endothelial inflammatory activation in vitro

Sophie Ellermann, Rianne M. Jongman, Matthijs Luxen et al. · Frontiers in Pharmacology · 2022 · 11 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Sepsis induces heterogeneous transcription of coagulation- and inflammation-associated genes in renal microvasculature

Matthijs Luxen, Peter J. Zwiers, Rianne M. Jongman et al. · Thrombosis Research · 2024 · 11 citations · Full text

Veterinary Medicine, Nephrology, Pathobiology +17

1–3 of 3